Safety study of new drug BMS-986521 in healthy volunteers
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult (male or female who cannot get pregnant).
- Your body mass index (BMI) must be between 18 and 32, and you must weigh at least 110 pounds (50 kg).
- You cannot have any significant medical condition (like heart, kidney, liver, or immune problems).
- You cannot have a history of cancer (except certain cured skin cancers) or blood disorders.
- You cannot have had a blood transfusion within the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This study tests a new drug called BMS-986521 using a special brain scan (PET scan) to see how well it attaches to certain receptors in the brain. It is for healthy volunteers to help understand how the drug works.
This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.
This trial tests a medicine called BMS-986368 in healthy Chinese adults. It measures how the drug moves through the body and checks for any side effects.
This trial tests how a drug (BMS-986435) behaves in people with normal liver function versus those with liver problems. It also checks that the drug is safe for the heart.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.